Area of research
Molecular Biology · Biomedical Engineering
Research interest
Research interests include RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery, and Immunotherapy and Immune Responses.
Pancreas-targeted lipid nanoparticles for relatively non-invasive interleukin-12 mRNA therapy in orthotopic pancreatic ductal adenocarcinoma
Integrated Smart Packaging of Modified Silica/Anthocyanin/Nanocellulose for Preservation and Monitoring
Large-scale As-Sb-S chalcogenide glasses with ultrahigh gradient refractive index
Design of minimalist broadband infrared optical system based on cemented chalcogenide glasses
Serotonergic modulation of vigilance states in zebrafish and mice
PRRX1-OLR1 axis supports CAFs-mediated lung cancer progression and immune suppression
<scp>NEDD4L</scp> affects <scp>KLF5</scp> stability through ubiquitination to control ferroptosis and radiotherapy resistance in oesophageal squamous cell carcinoma
Research on relationship between the thermo-physical parameters of green facade and leaf area index (LAI)
Curcumin mediates glutathione depletion via metal–organic framework nanocarriers to enhance cisplatin chemosensitivity on esophageal cancer
Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 <sup>+</sup> T cell response
Current Developments and Challenges of mRNA Vaccines
In Vitro Engineering Chimeric Antigen Receptor Macrophages and T Cells by Lipid Nanoparticle-Mediated mRNA Delivery
Self-Adaptive Nanomaterials for Rational Drug Delivery in Cancer Therapy
Rational construction of polycystine-based nanoparticles for biomedical applications
Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Smart transformable nanoparticles for enhanced tumor theranostics
Metal‐Polyphenol‐Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification
In situ cancer vaccination using lipidoid nanoparticles
A self-amplified nanocatalytic system for achieving “1 + 1 + 1 > 3” chemodynamic therapy on triple negative breast cancer
Preliminary Immunogenicity of a Pan-COVID-19 T Cell Vaccine in HLA-A*02:01 Mice
A multifunctional SN38-conjugated nanosystem for defeating myelosuppression and diarrhea induced by irinotecan in esophageal cancer
Construction of circRNA-Associated ceRNA Network Reveals Novel Biomarkers for Esophageal Cancer
Engineered nanomedicines with enhanced tumor penetration
A New Synthetic Allotetraploid (A1A1G2G2) between Gossypium herbaceum and G. australe: Bridging for Simultaneously Transferring Favorable Genes from These Two Diploid Species into Upland Cotton